Metal Nanoparticles in Infection and Immunity

Overview

Journal Immunol Invest

Publisher Informa Healthcare

Specialty Allergy & Immunology

Date 2020 Jun 12

PMID 32524902

Citations 10

Authors

John K Crane

Affiliations

Soon will be listed here.

Abstract

Background Enthusiasm for the use of metal nanoparticles in human and veterinary medicine is high. Many articles describe the effects of metal nanoparticles on microbes in vitro, and a smaller number of articles describe effects on the immune system, which is the focus of this review. Methods Articles were retrieved by performing literature searches in Medline, of the National Institute of Medicine, as well as via Google Scholar. Results In vitro studies show that metal nanoparticles have antimicrobial effects. Some metal nanoparticles augment innate host immune defenses, such as endogenous antimicrobial peptides, and nitric oxide. Metal nanoparticles may also function as vaccine adjuvants. Metal nanoparticles can migrate to locations distant from the site of administration, however, requiring careful monitoring for toxicity. Conclusions Metal nanoparticles show a great deal of potential as immunomodulators, as well as direct antimicrobial effects. Before metal particles can be adopted as therapies; however, more studies are needed to determine how nanoparticles migrate though the body and on possible adverse effects.

Citing Articles

Advancements in nanotheranostics for glioma therapy.

Sahoo L, Paikray S, Tripathy N, Fernandes D, Dilnawaz F Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39480526 DOI: 10.1007/s00210-024-03559-w.

Current research on ecotoxicity of metal-based nanoparticles: from exposure pathways, ecotoxicological effects to toxicity mechanisms.

Wang F, Zhou L, Mu D, Zhang H, Zhang G, Huang X Front Public Health. 2024; 12:1390099.

PMID: 39076413 PMC: 11284070. DOI: 10.3389/fpubh.2024.1390099.

Loading of green-synthesized cu nanoparticles on Ag complex containing 1,3,5-triazine Schiff base with enhanced antimicrobial activities.

Pormohammad E, Kargar P, Bagherzade G, Beyzaei H Sci Rep. 2023; 13(1):20421.

PMID: 37989862 PMC: 10663565. DOI: 10.1038/s41598-023-47358-4.

Metallic nanoparticle-coated sutures: a breakthrough in the field of surgery.

Khan A, Shahnoor S, Sajjad A Ann Med Surg (Lond). 2023; 85(3):555-556.

PMID: 36923752 PMC: 10010808. DOI: 10.1097/MS9.0000000000000162.

Metallic Structures: Effective Agents to Fight Pathogenic Microorganisms.

Pereira D, Carreira T, Alves N, Sousa A, Valente J Int J Mol Sci. 2022; 23(3).

PMID: 35163090 PMC: 8835760. DOI: 10.3390/ijms23031165.

References

Singh M, Kumar M, Kalaivani R, Manikandan S, Kumaraguru A . Metallic silver nanoparticle: a therapeutic agent in combination with antifungal drug against human fungal pathogen. Bioprocess Biosyst Eng. 2012; 36(4):407-15. DOI: 10.1007/s00449-012-0797-y. View

Lee J, Boman A, Sun C, Andersson M, Jornvall H, Mutt V . Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A. 1989; 86(23):9159-62. PMC: 298453. DOI: 10.1073/pnas.86.23.9159. View

Selim A, Elhaig M, Taha S, Nasr E . Antibacterial activity of silver nanoparticles against field and reference strains of Mycobacterium tuberculosis, Mycobacterium bovis and multiple-drug-resistant tuberculosis strains. Rev Sci Tech. 2019; 37(3):823-830. DOI: 10.20506/rst.37.3.2888. View

Huang L, Dai T, Xuan Y, Tegos G, Hamblin M . Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections. Antimicrob Agents Chemother. 2011; 55(7):3432-8. PMC: 3122390. DOI: 10.1128/AAC.01803-10. View

Shaikh S, Nazam N, Danish Rizvi S, Ahmad K, Baig M, Lee E . Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance. Int J Mol Sci. 2019; 20(10). PMC: 6566786. DOI: 10.3390/ijms20102468. View

Gregory A, Titball R, Williamson D . Vaccine delivery using nanoparticles. Front Cell Infect Microbiol. 2013; 3:13. PMC: 3607064. DOI: 10.3389/fcimb.2013.00013. View

Hirai T, Yoshioka Y, Izumi N, Ichihashi K, Handa T, Nishijima N . Metal nanoparticles in the presence of lipopolysaccharides trigger the onset of metal allergy in mice. Nat Nanotechnol. 2016; 11(9):808-16. DOI: 10.1038/nnano.2016.88. View

Zasloff M . Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A. 1987; 84(15):5449-53. PMC: 298875. DOI: 10.1073/pnas.84.15.5449. View

Falconer J, Alt J, Grainger D . Comparing ex vivo and in vitro translocation of silver nanoparticles and ions through human nasal epithelium. Biomaterials. 2018; 171:97-106. DOI: 10.1016/j.biomaterials.2018.04.013. View

10.

Orlowski P, Tomaszewska E, Gniadek M, Baska P, Nowakowska J, Sokolowska J . Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection. PLoS One. 2014; 9(8):e104113. PMC: 4130517. DOI: 10.1371/journal.pone.0104113. View

11.

Poon W, Alenius H, Ndika J, Fortino V, Kolhinen V, Mesceriakovas A . Nano-sized zinc oxide and silver, but not titanium dioxide, induce innate and adaptive immunity and antiviral response in differentiated THP-1 cells. Nanotoxicology. 2017; 11(7):936-951. DOI: 10.1080/17435390.2017.1382600. View

12.

Koshlukova S, Lloyd T, Araujo M, Edgerton M . Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem. 1999; 274(27):18872-9. DOI: 10.1074/jbc.274.27.18872. View

13.

Choi H, Ashitate Y, Lee J, Kim S, Matsui A, Insin N . Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol. 2010; 28(12):1300-3. PMC: 3058321. DOI: 10.1038/nbt.1696. View

14.

Shakibaie M, Forootanfar H, Ameri A, Adeli-Sardou M, Jafari M, Rahimi H . Cytotoxicity of biologically synthesised bismuth nanoparticles against HT-29 cell line. IET Nanobiotechnol. 2018; 12(5):653-657. PMC: 8676642. DOI: 10.1049/iet-nbt.2017.0295. View

15.

Habash M, Park A, Vis E, Harris R, Khursigara C . Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms. Antimicrob Agents Chemother. 2014; 58(10):5818-30. PMC: 4187931. DOI: 10.1128/AAC.03170-14. View

16.

Wang C, Liu X, Han Z, Zhang X, Wang J, Wang K . Nanosilver induces the formation of neutrophil extracellular traps in mouse neutrophil granulocytes. Ecotoxicol Environ Saf. 2019; 183:109508. DOI: 10.1016/j.ecoenv.2019.109508. View

17.

Habash M, Goodyear M, Park A, Surette M, Vis E, Harris R . Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms. Antimicrob Agents Chemother. 2017; 61(11). PMC: 5655055. DOI: 10.1128/AAC.00415-17. View

18.

Thompson E, Sayers B, Glista-Baker E, Shipkowski K, Taylor A, Bonner J . Innate Immune Responses to Nanoparticle Exposure in the Lung. J Environ Immunol Toxicol. 2015; 1(3):150-156. PMC: 4437698. DOI: 10.7178/jeit.23. View

19.

Cowper S, Robin H, Steinberg S, Su L, Gupta S, Leboit P . Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet. 2000; 356(9234):1000-1. DOI: 10.1016/S0140-6736(00)02694-5. View

20.

Pant J, Goudie M, Hopkins S, Brisbois E, Handa H . Tunable Nitric Oxide Release from S-Nitroso-N-acetylpenicillamine via Catalytic Copper Nanoparticles for Biomedical Applications. ACS Appl Mater Interfaces. 2017; 9(18):15254-15264. PMC: 8007131. DOI: 10.1021/acsami.7b01408. View